In News: Union Government has asked seven States to identify high-priority districts where the three-dose ZyCoV-D vaccine could be launched initially.
Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal, will identify the districts with high numbers of people who have not received the first dose, for introduction of ZyCoV-D.
The ‘Har Ghar Dastak’ nation-wide COVID-19 vaccination campaign has resulted in a hike of 5.9% in the first dose coverage [till November 30] and a jump of 11.7% in the second dose coverage has been registered during the campaign.
About Zycov-D
Zycov-D is a COVID-19 vaccine developed by the Ahmedabad based Zydus Cadilla group and is the first vaccine in India that can be administered to adults as well as those 12 and above.
It’s also the only DNA-based vaccine in the world and can be administered without a needle, minimizing chances of reactions.
The vaccine has been developed in partnership with the Department of Biotechnology under the ‘Mission COVID Suraksha’.
The three-dose vaccine once administered produces the spike protein of the SARS-CoV-2 virus and elicits an immune response.
The plug-and-play technology on which the plasmid DNA platform is based can be easily adapted to deal with mutations in the virus, such as those already occurring.
This is the fifth vaccine, after Covishield, Covaxin, Sputnik V and Moderna to be approved for use in India.